Provide participants with an overview of the current epidemiological situation of viral hepatitis infection worldwide and in the European Region of the World Health Organization (WHO)(WHO/EURO);
Provide participants with an overview of the Global Alliance for Vaccines and Immunization (GAVI) and the Global Fund for Children’s Vaccines (GFCV) and related activities in the European Region of WHO;
Provide an overview of the current status of hepatitis B vaccination globally and in the European Region of WHO/EURO;
Discuss hepatitis B prevention strategies in the broader context of viral hepatitis prevention and control (including injection safety, blood safety, and treatment of chronic hepatitis B and C infection);
Discuss country experiences with viral hepatitis prevention and control programmes;
Discuss programme planning in participating countries and develop meeting conclusions and plan of action for future activities;
Provide participants with general principles and strategies on the introduction of new antigens, with special focus on Hhepatitis B and Haeeamophilus influenzae type b;
Discuss mechanisms for strengthening national immunizsation systems, including in-country coordination, assessments, multi-year planning, financing, advocacy, and communication;
Provide a special training session for participants from GFCV-eligible countries on procedures and technical aspects of activities related to GAVI and GFCV.